46.46.Z - Wholesale trade of pharmaceutical and medical products
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
22.29.Z - Manufacture of rubber and plastic products
26.11.Z - Manufacture of electronic components
27.33.Z - Manufacture of installation equipment
32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
33.13.Z - Repair and maintenance of electronic and optical devices
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,9 | -0,6 | 0,2 | 128,1 |
EBITDA | 4,1 | 2,7 | 3 | 10,2 |
Short time liabilities | 4,4 | 4,2 | 2,6 | -39 |
Equity capital | 7,6 | 7 | 7,2 | 2,4 |
Operating profit (EBIT) | 1 | -0,3 | 0,2 | 163,3 |
Assets | 12,6 | 11,7 | 10,1 | -13,1 |
Net profit (loss) | 0,8 | -0,6 | 0,2 | 125,1 |
Cash | 0 | 0 | 0 | 174,1 |
Net income from sale | 13,3 | 11,8 | 12,2 | 2,7 |
Liabilities and provisions for liabilities | 4,9 | 4,6 | 2,9 | -36,9 |
Working assets | 5 | 4,8 | 4,9 | 3,5 |
Depreciation | 3,1 | 3,1 | 2,8 | -7,8 |
% | % | % | p.p. | |
Profitability of capital | 10,2 | -8,6 | 2,1 | 10,7 |
Equity capital to total assets | 60,7 | 60,4 | 71,2 | 10,8 |
Gross profit margin | 7 | -5,1 | 1,4 | 6,5 |
EBITDA Margin | 30,6 | 23,1 | 24,8 | 1,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 119 | 129 | 77 | -52 |
Current financial liquidity indicator | 1.1167434453964233 | 1.8924915790557861 | 0,8 | |
Net dept to EBITDA | 1.095747709274292 | 1.7762552499771118 | 1.0545780658721924 | -0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane